The Business Transformation & Operational Excellence World Summit and Industry Awards have announced its shortlist for the 2018 awards, naming Bristol-Myers Squibb (“BMS”) as a finalist in four categories.
BMS partnered with Gagen MacDonald to engage leaders and employees to understand enterprise and functional changes and do their part to focus resources, simplify work, and integrate efforts to deliver on the company’s ambitious, enterprise-wide transformation. Working broadly across the enterprise and deeply within each function, BMS and Gagen MacDonald utilized strategic change communication to introduce the operating model shift, support leaders to drive the change by listening and generating feedback, and engage employees around the organization’s new culture by shining a light on teams who are bringing the transformation to life by working in new ways. Through an extended period of significant change, the organization maintained focus on flawless delivery of critical medicines to patients who simply cannot wait.
BMS was named a finalist in the following four categories: “Best Achievement of Operational Excellence in Pharmaceuticals & Life Sciences,” “Best Achievement in Cultural Transformation & Sustainability to Deliver a High Performing Enterprise Excellence Culture,” “Best Achievement in Operational Excellence to Deliver an Outstanding Business Expansion and Revenue Growth,” and “Best Achievement in Operational Excellence to deliver an outstanding Value Creation or Innovation Execution project.”
The BTOES18 Awards recognize organizations around the world that have implemented operational excellence programs that have delivered outstanding business results.
An independent panel of esteemed experts in operational excellence selects the winners of the BTOES18 Awards. Award winners will be announced at the Business Transformation & Operational Excellence World Summit on March 14, 2018.
Peruse other awards Gagen MacDonald’s clients have earned.